Publication:
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.

No Thumbnail Available

Date

2022-01-01

Authors

Dichiara, Maria
Artacho-Cordón, Antonia
Turnaturi, Rita
Santos-Caballero, Miriam
González-Cano, Rafael
Pasquinucci, Lorella
Barbaraci, Carla
Rodríguez-Gómez, Isabel
Gómez-Guzmán, Manuel
Marrazzo, Agostino

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The development of σ1 receptor antagonists hybridized with a H2S-donor is here reported. We aimed to obtain improved analgesic effects when compared to σ1 receptor antagonists or H2S-donors alone. In an in vivo model of sensory hypersensitivity, thioamide 1a induced analgesia which was synergistically enhanced when associated with the σ1 receptor antagonist BD-1063. The selective σ1 receptor agonist PRE-084 completely reversed this effect. Four thioamide H2S-σ1 receptor hybrids (5a-8a) and their amide derivatives (5b-8b) were synthesized. Compound 7a (AD164) robustly released H2S and showed selectivity for σ1 receptor over σ2 and opioid receptors. This compound induced marked analgesia that was reversed by PRE-084. The amide analogue 7b (AD163) showed only minimal analgesia. Further studies showed that 7a exhibited negligible acute toxicity, together with a favorable pharmacokinetic profile. To the best of our knowledge, compound 7a is the first dual-acting ligand with simultaneous H2S-release and σ1 antagonistic activities.

Description

MeSH Terms

Animals
Guinea Pigs
Hydrogen
Hydrogen Sulfide
Ligands
Male
Morpholines
Pain
Piperazines
Rats, Sprague-Dawley
Receptors, sigma

DeCS Terms

CIE Terms

Keywords

Analgesia, Antagonist, Dual ligands, Hydrogen sulfide donor, Sigma-1 receptor

Citation